Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 of Fospropofol Disodium for Sedation in Elderly Patients Undergoing Lower Extremity Surgery
NCT07333508Phase 4Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fospropofol disodium in lower limb surgery. Primary endpoint: 95% Effective Dose of Fospropofol Disodium for Sedation. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
lower limb surgery
Beyond the preview
Go deeper on NCT07333508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07333508.